Emma Verástegui

Emma Verástegui

Auto-generated profile, based on publicly available information

Emma Verástegui

Servicio de Cuidados Paliativos, Instituto Nacional de Cancerología. Mexico City, Mexico

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 April 2017 in Supportive Care in Cancer
Verified
Journal Article
Closed access
PDF file
EMEdith Monreal-Carrillo
Edith Monreal-Carrillo
SASilvia Allende-Pérez
Silvia Allende-Pérez
DHDavid Hui
David Hui
MGMaria-Fernanda García-Salamanca
Maria-Fernanda García-Salamanca
EBEduardo Bruera
Eduardo Bruera
EVEmma Verástegui
Emma Verástegui

10 December 2009 in The European Journal of Health Economics
Verified
Journal Article
Open access
PDF file
EVEmma Verastegui
Emma Verastegui
AMAlejandro Mohar
Alejandro Mohar
Mexico, like many other middle-income countries, is experiencing a demographic and epidemiological transition resulting in an older population suffering from chronic diseases. At the present time, cancer is the second cause of death in the country. Until recently, cervical carcinoma was the most frequent type of cancer in the country, however, the incidence of breast, prostate and colon cancers is growing. The demand for health care and health expenditure represented by cancer treatment challenges the limited resources the country has, particularly as patients seek treatment in advanced stages of the disease. Interestingly enough, these types of cancers could be detected in the early stages with rather simple screening procedures. The purpose of this paper is to describe the Mexican health system, and the impact of its fragmentation on access to medicines. Focusing on colorectal cancer (CRC), we describe its epidemiology, screening procedures and the inequities in health care access for these patients.

13 July 2019 in Salud mental
Verified
Journal Article
Open access
OROscar Rodríguez-Mayoral
Oscar Rodríguez-Mayoral
LHLeticia Ascencio Huertas
Leticia Ascencio Huertas
EVEmma Verástegui
Emma Verástegui
MDMarvin O. Delgado-Guay
Marvin O. Delgado-Guay
ASAllende-Perez SIlvia
Allende-Perez SIlvia
Introduction. The desire to hasten death (DHD) might be present in patients with advanced cancer. Multiple distressing physical and psychosocial symptoms may be related to it. There is limited literature about the characteristics of these patients in México. Objective. To describe the prevalence and factors associated with DHD in advanced cancer patients evaluated by a palliative care psychiatrist. Method. We conducted a cross-sectional study, including all patients referred to psychiatric assessment at the Servicio de Cuidados Paliativos of the Instituto Nacional de Cancerología in Mexico City, from January to December 2016. DHD was defined as the presence of death ideas, suicidal ideation, and/or request for euthanasia or medically assisted suicide. Patients with delirium, dementia, psychosis, or uncontrolled physical symptoms were excluded. Results. Sixty-four patients were included in the study. Most of them were women (59%); the mean age was 49 years old (SD = 16). Of them, 64% met criteria for a major depressive disorder, 64% for generalized anxiety disorder and/or panic disorder, and 11% for substance use disorders. 44% expressed DHD. In a multivariate regression analysis predicting DHD, only one factor emerged: clinical depression (OR = 13.5, p = .002, 95% CI [02.562, 71.726]). Discussion and conclusion. The desire to hasten death is a frequent issue for the patients evaluated at the psychiatric palliative care clinic. Depression and other distressing psychiatric pathologies were associated with DHD. Interdisciplinary interventions are needed to treat DHD. More research is warranted in order to understand the factors associated with the expression of DHD.

13 November 2020 in International Journal of Gynecology & Obstetrics
Verified
Journal Article
Closed access
PDF file
SASilvia Allende‐Perez
Silvia Allende‐Perez
GDGeorgina Dominguez‐Ocadio
Georgina Dominguez‐Ocadio
VVVerónica Velez‐Salas
Verónica Velez‐Salas
DIDavid Isla‐Ortiz
David Isla‐Ortiz
APAdriana Peña‐Nieves
Adriana Peña‐Nieves
EVEmma Verastegui
Emma Verastegui

25 February 2022 in Salud Pública de México
Verified
Journal Article
Open access
ASAllende-Perez SIlvia
Allende-Perez SIlvia
APAdriana Peña-Nieves
Adriana Peña-Nieves
EMEdith Monreal-Carrillo
Edith Monreal-Carrillo
FGFernanda García-Salamanca
Fernanda García-Salamanca
LHLeticia Ascencio Huertas
Leticia Ascencio Huertas
EVEmma Verástegui
Emma Verástegui

1 January 2021 in Journal of Geriatric Oncology
Verified
Journal Article
Closed access
SASilvia Ros Allende-Pérez
Silvia Ros Allende-Pérez
JSJosafat Napoleón Sánchez-Dávila
Josafat Napoleón Sánchez-Dávila
APAdriana Peña-Nieves
Adriana Peña-Nieves
EVEmma Verástegui
Emma Verástegui